Table 1.

MYH10, MYH9, or MYH10/MYH9 expression in association with standard clinicopathological variables using the χ2 or Fisher's exact test

Parameters		Total	MYH10			MYH9			Co‐expression of MYH10/MYH9
			Low	High	p‐value (χ2 or Fisher's exact test)	Low	High	p‐value (χ2 or Fisher's exact test)	MYH10+/MYH9+	Others	p‐value (χ2 or Fisher's exact test)
Age (years)	≤50	54	13	41	0.6271	13	41	0.3910	32	22	0.2372
	>50	78	16	62		14	64		54	24
FIGO stage	I/II	16	10	6	<0.0001	7	9	0.0137	3	13	<0.0001
	III/IV	116	19	97		20	96		83	33
Lymph node metastasis	No	23	9	14	0.1999	8	15	0.3259	11	12	0.2342
	Yes	23	5	18		5	18		15	8
Intraperitoneal metastasis	No	24	13	11	<0.0001	11	13	0.0007	7	17	<0.0001
	Yes	108	16	92		16	92		79	29
Intestinal metastasis	No	54	17	37	0.0281	16	38	0.0297	28	26	0.0076
	Yes	78	12	66		11	67		58	20
Vital status	Alive	59	16	43	0.8540	17	42	0.0889	33	26	0.2018
	Dead	47	12	35		7	40		32	15
Intraperitoneal recurrence	No	87	22	65	0.3315	21	66	0.1311	53	34	0.2050
	Yes	40	7	33		5	35		29	11
Distant recurrence	No	107	26	81	0.3632	24	83	0.2060	63	44	0.1740
	Yes	20	3	17		2	18		15	5
Differentiation Grade	G1/G2	38	10	28	0.3312	7	31	0.6508	24	14	0.6721
	G3	91	17	74		20	71		61	30
Platinum resistance	No	129	28	101	0.3951	29	100	>0.9999	84	45	>0.9999
	Yes	2	1	1		0	2		1	1
Ascites with tumor cells	No	21	10	11	0.0002	8	13	0.0470	8	13	0.0012
	Yes	29	1	28		4	25		24	5
CA125 [U mL−1]	≤35	9	2	7	0.9416	2	7	0.8426	6	3	0.9316
	>35	118	25	93		23	95		77	41
CA153 [U mL−1]	≤25	8	3	5	0.3918	1	7	0.8954	4	4	0.4068
	>25	35	8	27		5	30		23	12
CEA [U mL−1]	≤5	106	25	81	>0.9999	21	85	>0.9999	68	38	>0.9999
	>5	4	1	3		0	4		3	1
HE4 [U mL−1]	≤140	16	5	11	0.0759	6	10	0.2529	7	9	0.0275
	>140	56	7	49		13	43		41	15